Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 229.22 USD 2.43%
Market Cap: 6.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+31%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

BIO Price Targets Summary
Bio Rad Laboratories Inc

Wall Street analysts forecast BIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIO is 333.54 USD with a low forecast of 262.6 USD and a high forecast of 411.6 USD.

BIO Lowest Forecast
Wall Street Target
262.6 USD
15% Upside
BIO Average Forecast
Wall Street Target
333.54 USD
46% Upside
BIO Highest Forecast
Wall Street Target
411.6 USD
80% Upside
Lowest
Price Target
262.6 USD
15% Upside
Average
Price Target
333.54 USD
46% Upside
Highest
Price Target
411.6 USD
80% Upside
Bio Rad Laboratories Inc Competitors:
Price Targets
VIMTALABS
Vimta Labs Ltd
40% Downside
AZTA
Azenta Inc
82% Upside
207940
Samsung Biologics Co Ltd
34% Upside
603108
Shanghai Runda Medical Technology Co Ltd
35% Upside
VIMTALABS
Vimta Labs Ltd
40% Downside
AZTA
Azenta Inc
82% Upside
207940
Samsung Biologics Co Ltd
34% Upside
603108
Shanghai Runda Medical Technology Co Ltd
35% Upside
DIM
Sartorius Stedim Biotech SA
28% Upside
4880
CellSource Co Ltd
38% Upside
1548
Genscript Biotech Corp
85% Upside
GSS
Genetic Signatures Ltd
93% Upside

Revenue
Forecast

Revenue Estimate
Bio Rad Laboratories Inc

For the last 8 years the compound annual growth rate for Bio Rad Laboratories Inc's revenue is 3%. The projected CAGR for the next 3 years is 2%.

3%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Bio Rad Laboratories Inc

For the last 8 years the compound annual growth rate for Bio Rad Laboratories Inc's operating income is 11%. The projected CAGR for the next 3 years is 13%.

11%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Bio Rad Laboratories Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIO stock valuation using valuation multiples.
Wall Street Estimates
BIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIO's stock price target?
Price Target
333.54 USD

According to Wall Street analysts, the average 1-year price target for BIO is 333.54 USD with a low forecast of 262.6 USD and a high forecast of 411.6 USD.

What is Bio Rad Laboratories Inc's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Bio Rad Laboratories Inc's revenue is 3%. The projected CAGR for the next 3 years is 2%.

What is Bio Rad Laboratories Inc's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Bio Rad Laboratories Inc's operating income is 11%. The projected CAGR for the next 3 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.